Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
49.41
+3.13 (6.76%)
At close: Jun 27, 2025, 4:00 PM
49.36
-0.05 (-0.10%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Hims & Hers Health stock ranges from a low of $23 to a high of $68. The average analyst price target of $38 forecasts a -23.09% decrease in the stock price over the next year.
Price Target: $38.00 (-23.09%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 4 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 7 | 6 | 7 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Reiterates $40 | Hold | Reiterates | $40 | -19.04% | Jun 11, 2025 |
| Needham | Needham | Strong Buy Maintains $61 → $65 | Strong Buy | Maintains | $61 → $65 | +31.55% | Jun 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $35 → $39 | Hold | Reiterates | $35 → $39 | -21.07% | May 6, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $25 → $30 | Strong Sell | Maintains | $25 → $30 | -39.28% | May 6, 2025 |
| Needham | Needham | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +23.46% | May 6, 2025 |
Financial Forecast
Revenue This Year
2.40B
from 1.48B
Increased by 62.41%
Revenue Next Year
2.87B
from 2.40B
Increased by 19.85%
EPS This Year
0.68
from 0.53
Increased by 28.61%
EPS Next Year
0.97
from 0.68
Increased by 41.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5B | 3.2B | 4.1B | ||
| Avg | 2.4B | 2.9B | 3.5B | ||
| Low | 2.3B | 2.5B | 3.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.1% | 32.2% | 43.9% | ||
| Avg | 62.4% | 19.8% | 20.6% | ||
| Low | 52.8% | 4.1% | 3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.02 | 1.56 | 1.92 |
| Avg | 0.68 | 0.97 | 1.29 |
| Low | 0.34 | 0.44 | 0.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 91.4% | 128.6% | 98.3% |
| Avg | 28.6% | 41.6% | 32.9% |
| Low | -35.6% | -35.6% | -5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.